Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study.

Ther Adv Neurol Disord · 2026 · PMC12921211 · PMID 41726319

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Subscore analysis indicated marginally significant antibody × time interactions for ocular and axial QMGS over the 6 months ( Table S5, Figure S2(B) and (E) ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.